GlassScriptPhysician profile
Susan Macdowell
NPI 1306170352
$6,650.27
in general payments reported to CMS, 2019-2025
56 companies · $988 in 2025
The $988 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $1,813 · 2023: $1,348 · 2024: $2,361 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,274 · Education: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,273.76 |
| Education | $422.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,204.68 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $393.93 | 2023-2025 | Imfinzi, Calquence, Enhertu |
| Celgene Corporation | $365.35 | 2024-2025 | Reblozyl |
| Astellas Pharma US INC | $310.96 | 2021-2024 | Xtandi, Cresemba, Xospata |
| Lilly USA, LLC | $303.89 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Novartis Pharmaceuticals Corporation | $287.26 | 2023-2025 | |
| Adaptive Biotechnologies Corporation | $286.72 | 2023-2025 | Clonoseq |
| Urovant Sciences INC | $257.08 | 2021-2022 | |
| Beigene USA, INC. | $242.15 | 2024 | Brukinsa, Tevimbra |
| Pfizer INC. | $240.01 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $216.02 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $198.22 | 2023-2024 | Enhertu |
| Seagen INC. | $162.08 | 2023-2025 | Adcetris, Tukysa |
| Janssen Biotech, INC. | $160.27 | 2024-2025 | Rybrevant, Tecvayli, Talvey |
| Abbvie INC. | $157.39 | 2022-2024 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $149.77 | 2021-2022 | |
| Incyte Corporation | $147.04 | 2023-2025 | Monjuvi, Jakafi |
| Kite Pharma, INC. | $116.99 | 2023 | Yescarta |
| Genzyme Corporation | $91.13 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $86.18 | 2024-2025 | Opdivo, Augtyro, Krazati |
| Teleflex LLC | $77.10 | 2023 | Urolift |
| Sanofi-Aventis U.S. LLC | $74.05 | 2023 | |
| Sobi, INC | $73.73 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $72.43 | 2023-2025 | Ultomiris |
| Dentsply Ih Ab | $68.78 | 2023 | Lofric |
| Pharmacosmos Therapeutics INC. | $68.62 | 2023-2024 | Monoferric, Cosela |
| Array Biopharma INC | $63.50 | 2024-2025 | Mektovi, Braftovi, Tukysa |
| Glaxosmithkline, LLC. | $53.53 | 2023-2024 | Ojjaara, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $50.29 | 2024 | Fruzaqla |
| Sumitomo Pharma America, INC. | $46.02 | 2023 | Orgovyx, Gemtesa |
| Jazz Pharmaceuticals INC. | $42.25 | 2025 | |
| Aveo Pharmaceuticals, INC. | $41.14 | 2024-2025 | |
| G1 Therapeutics, INC. | $39.55 | 2023 | Cosela |
| Emd Serono, INC. | $38.24 | 2025 | |
| Myriad Genetic Laboratories, INC. | $35.56 | 2021-2022 | |
| Dentsply Ih INC. | $34.92 | 2022 | |
| Genmab U.S., INC. | $29.76 | 2023 | Epkinly |
| 180 Medical, INC. | $29.63 | 2021 | |
| Procept Biorobotics Corporation | $27.44 | 2023 | Aquabeam Robotic System |
| Stemline Therapeutics INC. | $26.75 | 2023 | Orserdu |
| Urogen Pharma, INC. | $22.94 | 2022 | |
| Beone Medicines USA, INC. | $22.44 | 2025 | Brukinsa |
| Eisai INC. | $22.32 | 2023 | |
| Hologic Sales and Service, LLC | $21.04 | 2024 | Novasure |
| Endo Pharmaceuticals INC. | $19.40 | 2023 | Aveed, Xiaflex |
| Adc Therapeutics America, INC. | $18.42 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.71 | 2023 | |
| Cti Biopharma Corp. | $17.11 | 2023 | Vonjo |
| Telix Pharmaceuticals | $16.34 | 2022 | |
| Deciphera Pharmaceuticals INC. | $15.90 | 2024 | Qinlock |
| Dendreon Pharmaceuticals LLC | $15.71 | 2024 | Provenge |
| Mirati Therapeutics, INC. | $14.57 | 2024 | Krazati |
| Legend Biotech USA INC. | $14.45 | 2025 | Carvykti |
| Puma Biotechnology, INC. | $14.35 | 2024 | |
| Antares Pharma, INC. | $14.34 | 2021 | |
| Amgen INC. | $12.82 | 2023 | Vectibix, Nplate, Xgeva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Macdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.